Literature DB >> 12522039

Alterations in T-cell receptor Vbeta repertoire of CD4 and CD8 T lymphocytes in human immunodeficiency virus-infected children.

Monica Kharbanda1, Thomas W McCloskey, Rajendra Pahwa, Mei Sun, Savita Pahwa.   

Abstract

Perturbations in the T-cell receptor (TCR) Vbeta repertoire were assessed in the CD4 and CD8 T lymphocytes of human immunodeficiency virus (HIV)-infected children who were receiving therapy during the chronic phase of infection by flow cytometry (FC) and PCR analysis. By FC, representation of 21 TCR Vbeta subfamilies was assessed for an increased or decreased percentage in CD4 and CD8 T cells, and by PCR, 22 TCR Vbeta subfamilies of CD4 and CD8 T cells were analyzed by CDR3 spectratyping for perturbations and reduction in the number of peaks, loss of Gaussian distribution, or clonal dominance. The majority of the TCR Vbeta subfamilies were examined by both methods and assessed for deviation from the norm by comparison with cord blood samples. The CD8-T-lymphocyte population exhibited more perturbations than the CD4 subset, and clonal dominance was present exclusively in CD8 T cells. Of the 55 total CD8-TCR Vbeta families classified with clonal dominance by CDR3 spectratyping, only 18 of these exhibited increased expression by FC. Patients with high numbers of CD8-TCR Vbeta families with decreased percentages had reduced percentages of total CD4 T cells. Increases in the number of CD4-TCR Vbeta families with increased percentages showed a positive correlation with skewing. Overall, changes from normal were often discordant between the two methods. This study suggests that the assessment of HIV-induced alterations in TCR Vbeta families at cellular and molecular levels yields different information and that our understanding of the immune response to HIV is still evolving.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522039      PMCID: PMC145262          DOI: 10.1128/cdli.10.1.53-58.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  28 in total

1.  Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection.

Authors:  J Mongkolsapaya; A Jaye; M F Callan; A F Magnusen; A J McMichael; H C Whittle
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

2.  T-cell antigen receptor V beta subsets are not preferentially deleted in AIDS.

Authors:  D N Posnett; S Kabak; A S Hodtsev; E A Goldberg; A Asch
Journal:  AIDS       Date:  1993-05       Impact factor: 4.177

3.  HIV preferentially infects HIV-specific CD4+ T cells.

Authors:  Daniel C Douek; Jason M Brenchley; Michael R Betts; David R Ambrozak; Brenna J Hill; Yukari Okamoto; Joseph P Casazza; Janaki Kuruppu; Kevin Kunstman; Steven Wolinsky; Zvi Grossman; Mark Dybul; Annette Oxenius; David A Price; Mark Connors; Richard A Koup
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

4.  Apoptosis in T-lymphocyte subsets in human immunodeficiency virus-infected children measured immediately ex vivo and following in vitro activation.

Authors:  T Niehues; T W McCloskey; J Ndagijimana; G Horneff; V Wahn; S Pahwa
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

Review 5.  Human immunodeficiency virus infection in children: nature of immunodeficiency, clinical spectrum and management.

Authors:  S Pahwa
Journal:  Pediatr Infect Dis J       Date:  1988-05       Impact factor: 2.129

6.  Patterns of CD8 T cell clonal dominance in response to change in antiretroviral therapy in HIV-infected children.

Authors:  M Kharbanda; S Than; V Chitnis; M Sun; S Chavan; S Bakshi; S Pahwa
Journal:  AIDS       Date:  2000-10-20       Impact factor: 4.177

7.  Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection.

Authors:  J N Blattman; D J Sourdive; K Murali-Krishna; R Ahmed; J D Altman
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

8.  Transient T cell receptor beta-chain variable region-specific expansions of CD4+ and CD8+ T cells during the early phase of pediatric human immunodeficiency virus infection: characterization of expanded cell populations by T cell receptor phenotyping.

Authors:  H Soudeyns; P Champagne; C L Holloway; G U Silvestri; N Ringuette; J Samson; N Lapointe; R P Sékaly
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

9.  T cell receptor V beta repertoire of the antigen specific CD8 T lymphocyte subset of HIV infected children.

Authors:  Thomas W McCloskey; Viraga Haridas; Rajendra Pahwa; Savita Pahwa
Journal:  AIDS       Date:  2002-07-26       Impact factor: 4.177

10.  HIV infection leads to differential expression of T-cell receptor V beta genes in CD4+ and CD8+ T cells.

Authors:  V L Hodara; M Jeddi-Tehrani; J Grunewald; R Andersson; G Scarlatti; S Esin; V Holmberg; O Libonatti; H Wigzell
Journal:  AIDS       Date:  1993-05       Impact factor: 4.177

View more
  13 in total

1.  T cell receptor Vbeta repertoire of T lymphocytes and T regulatory cells by flow cytometric analysis in healthy children.

Authors:  A McLean-Tooke; D Barge; G P Spickett; A R Gennery
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

2.  Simplified fluorescent multiplex PCR method for evaluation of the T-cell receptor V beta-chain repertoire.

Authors:  Sanjit Fernandes; Surendra Chavan; Vivek Chitnis; Nina Kohn; Savita Pahwa
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

3.  Characterization of the T-cell receptor Vbeta repertoire in the human immune response against Leishmania parasites.

Authors:  Jorge Clarêncio; Camila I de Oliveira; Glória Bomfim; Margarida M Pompeu; Maria Jania Teixeira; Theolis C Barbosa; Sebastião Souza-Neto; Edgar M Carvalho; Cláudia Brodskyn; Aldina Barral; Manoel Barral-Netto
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

4.  Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life.

Authors:  Nazma Mansoor; Brian Abel; Thomas J Scriba; Jane Hughes; Marwou de Kock; Michele Tameris; Sylvia Mlenjeni; Lea Denation; Francesca Little; Sebastian Gelderbloem; Anthony Hawkridge; W Henry Boom; Gilla Kaplan; Gregory D Hussey; Willem A Hanekom
Journal:  Clin Immunol       Date:  2008-11-08       Impact factor: 3.969

5.  Impaired T-cell differentiation in diabetic foot ulceration.

Authors:  João Moura; João Rodrigues; Marta Gonçalves; Cláudia Amaral; Margarida Lima; Eugénia Carvalho
Journal:  Cell Mol Immunol       Date:  2016-03-21       Impact factor: 11.530

6.  Distribution and evolution of T-cell receptor Vbeta repertoire on peripheral blood lymphocytes of newborn infants of human immunodeficiency virus (HIV)-infected mothers: differential display on CD4 and CD8 T cells and effect of HIV infection.

Authors:  William Borkowsky; Song-He Chen; Ilana Belitskaya-Levy
Journal:  Clin Vaccine Immunol       Date:  2007-07-25

7.  Shorter TCR β-Chains Are Highly Enriched During Thymic Selection and Antigen-Driven Selection.

Authors:  Xianliang Hou; Ping Zeng; Xujun Zhang; Jianing Chen; Yan Liang; Jiezuan Yang; Yida Yang; Xiangdong Liu; Hongyan Diao
Journal:  Front Immunol       Date:  2019-02-26       Impact factor: 7.561

Review 8.  Role of the Fas/FasL pathway in HIV or SIV disease.

Authors:  Bhawna Poonia; C David Pauza; Maria S Salvato
Journal:  Retrovirology       Date:  2009-10-15       Impact factor: 4.602

9.  T-cell receptor phenotype pattern in atopic children using commercial fluorescently labeled antibodies against 21 human class-specific v segments for the tcrβ chain (vβ) of peripheral blood: a cross sectional study.

Authors:  Gassem Gohal; Christine McCusker; Bruce Mazer; Reza Alizadehfar; Duncan Lejtenyi; Moshe Ben-Shoshan
Journal:  Allergy Asthma Clin Immunol       Date:  2016-03-02       Impact factor: 3.406

10.  Dynamic Perturbations of the T-Cell Receptor Repertoire in Chronic HIV Infection and following Antiretroviral Therapy.

Authors:  James M Heather; Katharine Best; Theres Oakes; Eleanor R Gray; Jennifer K Roe; Niclas Thomas; Nir Friedman; Mahdad Noursadeghi; Benjamin Chain
Journal:  Front Immunol       Date:  2016-01-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.